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ABSTRACT
Periodontal tissue damage requires regenerative material to repair the damage. Platelet-rich plasma (PRP) is known 
as a regenerative material from blood which contains high level of growth factor that plays a role in wound healing and 
tissue remodeling. However PRP has a weakness, i.e. it is too watery so it is easily dissolved in the oral cavity, and 
should be used immediately after preparation. Therefore PRP storage method is needed to increase the benefits 
of PRP. The addition of collagen to PRP serves as a scaffold as well as an activator that stimulates the release of 
growth factors. One method of storing PRP is by freeze-drying process. The purpose of this study was to analyze the 
effect of freeze-drying process of collagen-activated PRP (PRP+C) on transforming growth factor-β1 (TGF-β1) levels. 
Transforming growth factor-β1 is a cytokine content in PRP, that plays a role in bone remodeling and is an important 
stimulator for osteoblast formation, causing chemotaxis, osteoblast proliferation and differentiation. In this study, PRP 
w a s  produced from peripheral blood probandus. Platelet-rich plasma was then activated with collagen (PRP+C), 
and divided into two groups: freeze-dried PRP collagen (FD PRP+C); and non freeze-dried PRP+collagen (PRP+C). 
Transforming growth factor-β1 levels were measured using the ELISA method, followed by independent t-test. The 
TGF-B1 level of FD PRP+C group was significantly higher than PRP+C group (p<0.05). From this study it can be 
concluded that freeze-dried collagen-activated PRP has an effect to increase TGF-β1 level.
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INTRODUCTION
Periodontal disease is a multifactorial and complex 
condition that affects the periodontium. It is 
characterized by the loss of collagen membrane with 
the subsequent destruction of periodontal tissues. 
One of the consequences of periodontal disease 
(periodontitis) is periodontal intrabony defects. 
There is a growing interest in the use of platelet-rich 
plasma (PRP) for the treatment of intrabony pocket 
since it is a concentrated source of autologous 
platelets enriched with several growth factors.1 
Platelet-rich plasma (PRP) is an autologous source 
of several growth factors, such as platelet-derived 
growth factor (PDGF), transforming growth factor 
(TGF)-β, insulin growth factor (IGF), vascular 
endothelial growth factor (VEGF), platelet-derived 
endothelial cells growth factor (PDECGF), platelet-
derived angiogenesis factor (PDAF) and fibroblast 
growth factor (FGF).2 
Autologous PRP is usually prepared before 
surgery and immediately used after preparation. 
This leads to longer duration of patient treatment 
and also requires more operators.3 Homologous 
PRP is a PRP prepared from donor blood which 
can be used by other patients after cross-matched 
processes.4,5 Human platelet concentrates are 
usually stored in a blood bag at 22 °C with a 
shelf life of 3-7 days, according to the standard of 
blood bank. This limits the availability of platelets 
to address emergency needs.6 It would be most 
effective if PRP can be isolated first and stored until 
the time of use.3
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Platelet storage  method at room temperature 
in the long term was introduced by lyophilization 
or freeze-drying techniques. The ability to store 
PRP for a long time and keep the cytokines therein 
contained will eventually expand its clinical use. 
This allows for the taking of a patient’s blood 
sample then stored and used several times at 
later time.3,6 Shiga et al in their study concluded 
that PRP activated using calcium chloride 
(CaCl2) + thrombin then freeze-dried and stored 
within eight weeks had the same growth factor as 
fresh PRP, whereas PRP stored in room temperature 
and frozen has decreased levels of growth factor 
significantly.7 Research by Pan et al concluded that 
PRP activated using CaCl2 then freeze-dried and 
stored for four weeks at room temperature had 
higher levels of TGF-β1 than PRP activated using 
CaCl2 without freeze drying at 15 min incubation.
6
Transforming Growth Factor (TGF)-β1 is a 
growth factor contained in PRP, which is released 
in large amounts after activation.6 Measurement of 
TGF-β1 levels is a representative way to assess the 
cytokine content present in PRP. Study on TGF-β1 
levels needs to be done to determine the effect of 
freeze-drying process on the cytokines contained 
in PRP.
MATERIALS AND METHODS
The protocol of this study was approved by the 
ethics committee of Faculty of Dentistry Universitas 
Gadjah Mada with registration number 001250/
KKEP/FKG-UGM/EC/2017. This experimental study 
used blood from human subject of which the 
inclusion criteria were: having normal platelet count 
confirmed with routine blood test, and no abnormal 
bleeding history.
Forty mL of donor blood was taken from artery 
antecubital and 9 mL was separated into each 
vacutainer tube. One mL of 3.8% sodium citrate 
was added as anticoagulant. Platelet-rich plasma 
was prepared by differential centrifugation. An initial 
centrifugation was done at 1200 rpm for 10 minutes 
(EBA 200 Hettich, America). This first centrifugation 
was separated into two layers: platelet-poor plasma 
(PPP) in the upper layer and red blood cells in the 
second layer. Platelet poor plasma was separated 
using 3 way stopcock (Onemed), followed by 
centrifugation at 3500 rpm for 10 minutes. The 
second centrifugation resulted in PRP on one-third 
of the bottom layers while PPP at two-third of the 
top layer. Three way stopcock was used to separate 
PRP. 
Activation of PRP was obtained by mixing the 
PRP supernatant and Collacure collagen sponge, 
the volume ratio was 1 mL:1 mg. Then an aliquot 
was divided into two groups (FD PRP+C and 
PRP+C), each was incubated for two hours. 
Freeze drying procedure was done by freezing 
PRP+C at -40 °C for 12 hours, then drying for 48 
hours using freeze-drier machine (Freeze Dryer 
Modulyo, Edwards).3 The sample of FD PRP+C 
was resuspended using a sterile distilled water 
before ELISA procedure. After resuspension, FD 
PRP+C weight was adjusted to be the same as the 
weight before freeze-drying to avoid change of FD 
PRP+C component concentration.7
The concentration of TGF-β1 was quantified by 
using Colorimetric Enzyme-Linked Immunosorbent 
Assay (ELISA) (Quantikine ELISA Human TGF-β1, 
RnD System, USA) method at 450 nm wave length. 
The concent ra t ion  of TGF-β1 was obtained in 
units of pg/mL by using curve expert version 1.2 
software. SPSS program version 22.0 was used to 
analyze data.
RESULTS
We quantified TGF-β1 of FD PRP+C and PRP+C. 
Table 1 shows the mean and standard deviation of 
TGF-β1 of FD PRP+C and PRP+C. 
As presented in Table 1, the TGF-β1 level 
of FD PRP+C group was higher than that of the 
PRP+C group. The results for the normality and 
homogeneity tests showed that the data of TGF-β1 
were normally distributed and homogenous 
(p>0.05). In order to determine the mean 
differences between the two groups, Independent 
t-test parametric test was done. Table 2 indicates 
that the difference of TGF-β1 levels between the 
FD PRP+C and PRP+C groups was significant.
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Table 1. Level of TGF β1 in FD PRP+C and PRP+C group
Group (n)
Number of 
samples
Mean and standard 
deviation (pg/mL)
FD PRP+c 12 3067.76 ± 166.50
PRP+c 12 1590.47 ± 128.87
Table 2. Result of Independent t-test of TGF-β1 level between 
FD PRP+C and PRP+C groups
T df
Sig. 
(2-tailed)
Mean
Standard 
error
difference difference
t-test for 
equal means
24.306 22 .000* 1477.29583 60.77863
*: p value significant
DISCUSSION
This study indicated that the mean TGF-β1 growth 
factor in the FD PRP+C group was higher than 
that in the PRP+C group. This is supported by 
the statistical analysis of independent t-test which 
showed that there was a significant difference 
between the two groups. The results are in 
accordance with the proposed theoretical basis, 
that freeze-drying process can maintain the content 
of cytokines, as well as increase the levels of 
growth factor (in this study is TGF-β1) in the group 
of FD PRP+C.
The possible cause of these outcomes is that 
in the group of FD PRP+C, platelets are activated 
biochemically and physically. According to Textor,8 
platelet stimuli can be physical, chemical, or a 
combination of both. Biochemical activation occurs 
when collagen is incorporated into PRP. Collagen-
induced platelet activation process begins with 
collagen bonding with a glycoprotein VI receptor. 
This  bond induces several sets of intracellular 
signals, on one side activating the α2β1 intergrins 
which then bind to other collagen molecules. The 
collagen bond with these two main receptors then 
induces an intracellular signaling cascade that 
leads to calcium release and activation of protein 
kinase C. Both are responsible for platelet response 
to signal sequence. The platelet response is in 
the form of aggregation and release of granular 
content through exocytosis.9 Fufa et al in their study 
concluded that the use of type I collagen to activate 
PRP may be safe and effective, and have an equal 
release of growth factor compared with currently 
available methods of PRP activation.10
The freeze-drying process includes freezing 
PRP at -40 °C then sublimation by lowering air 
pressure and raising the temperature to 38 °C. 
This is a way to rupture cell membranes by thermal 
lysis method. Rupture of cell membrane occurs 
due to the formation of ice on the cell membrane, 
causing it to be easily broken, consequently 
platelets will release the growth factor contained in 
it.11 Thus PRP will be physically activated because 
of the freeze-drying process. The combination of 
collagen-activated and freeze-dried PRP causes 
TGF-β1 contained in the FD PRP+C group to be 
higher than that in the PRP+C group. 
According to Nakatani et al the use of freeze-
dried collagen-activated PRP in patients requiring 
surgical periodontal therapy can be done by 
considering several things, such as the sterility of 
the material to be used.3 In fact, during preparing 
and freeze-drying PRP, it is possible for bacterial 
contamination to take place. Sterilization should be 
performed before freeze-dried collagen-activated 
PRP is used for clinical purposes. Usri suggests 
the use of γ beam radiation at a minimum dose of 
25 kGy for sterilization of graft material.12
CONCLUSION
Based on the research that has been done, it 
can be concluded that freeze-drying process of 
collagen-activated PRP has an effect to increase 
TGF-β1 level.
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